Evans Elizabeth E. 4
4 · VACCINEX, INC. · Filed Apr 3, 2023
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Evans Elizabeth E.
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+40,000→ 40,000 totalExercise: $0.40Exp: 2033-03-30→ Common Stock (40,000 underlying)
Holdings
- 9,600
Common Stock
- 9,610
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (9,610 underlying) - 8,605
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (8,605 underlying) - 12,400
Stock Option (Right to Buy)
Exercise: $3.90Exp: 2029-03-14→ Common Stock (12,400 underlying) - 8,000
Stock Option (Right to Buy)
Exercise: $2.93Exp: 2031-04-03→ Common Stock (8,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $3.82Exp: 2030-04-04→ Common Stock (10,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $1.29Exp: 2032-04-01→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]This option is fully exercisable as of the date of this report.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 3, 2020 grant date.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
- [F4]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
- [F5]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.